These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 17974088)

  • 1. Doctors with multi-state practices beware: new DEA regulation could affect you.
    Ball FR
    J Med Pract Manage; 2007; 23(2):104-5. PubMed ID: 17974088
    [No Abstract]   [Full Text] [Related]  

  • 2. Dear DEA.
    Heit HA; Covington E; Good PM
    Pain Med; 2004 Sep; 5(3):303-8. PubMed ID: 15367311
    [No Abstract]   [Full Text] [Related]  

  • 3. DEA issues proposed rule on e-prescribing.
    Ball FR
    J Med Pract Manage; 2009; 24(4):243. PubMed ID: 19288650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why is the DEA hounding this doctor?
    Roosevelt M
    Time; 2005 Jul; 166(4):56-8. PubMed ID: 16075844
    [No Abstract]   [Full Text] [Related]  

  • 5. New Drug Enforcement Administration guideline for communicating controlled substance prescriptions to pharmacies.
    Drug Enforcement Adminstration U S Department of Justice
    J Pain Palliat Care Pharmacother; 2011; 25(1):83-9. PubMed ID: 21426229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DEA grants prescriber numbers to certain Massachusetts pharmacists.
    J Pain Palliat Care Pharmacother; 2011; 25(3):297-9. PubMed ID: 21998842
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacists correcting schedule II prescriptions: DEA flip-flops continue.
    Abood RR
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):393-6. PubMed ID: 21133749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Drug Enforcement Agency and DEA Form 104.
    Stratton WT
    Kans Med; 1994 Oct; 95(10):212, 214. PubMed ID: 7815771
    [No Abstract]   [Full Text] [Related]  

  • 9. The DEA issues new clarification regarding prescribing schedule II controlled substances.
    Heitz R
    WMJ; 2005 Apr; 104(3):55. PubMed ID: 15966635
    [No Abstract]   [Full Text] [Related]  

  • 10. From balanced pain care to drug trafficking: the case of Dr. William Hurwitz and the DEA.
    Fishman SM
    Pain Med; 2005; 6(2):162-4. PubMed ID: 15773882
    [No Abstract]   [Full Text] [Related]  

  • 11. Clarification of registration requirements for individual practitioners. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2006 Dec; 71(231):69478-80. PubMed ID: 17171847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescriptions; requirements clarification--Drug Enforcement Administration (DEA). Final rule.
    Fed Regist; 1991 Jun; 56(106):25025-7. PubMed ID: 10111144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescribers can't completely eliminate paper--yet.
    Edwards DJ
    Behav Healthc; 2008 Feb; 28(2):39. PubMed ID: 18389656
    [No Abstract]   [Full Text] [Related]  

  • 14. Dispensing, prescribing and administering drugs: what you need to know.
    MDA Special Committee on Care and Well Being
    J Mich Dent Assoc; 2010 Mar; 92(3):46-50. PubMed ID: 20391816
    [No Abstract]   [Full Text] [Related]  

  • 15. Supreme Court: your office can be searched without a warrant.
    Crane M
    Med Econ; 2000 Jun; 77(11):43, 46. PubMed ID: 11010263
    [No Abstract]   [Full Text] [Related]  

  • 16. Pain meds in the spotlight. Senate staffers get demo of DEA regulations.
    Connole P
    Provider; 2010 Feb; 36(2):20-1. PubMed ID: 20183969
    [No Abstract]   [Full Text] [Related]  

  • 17. The federal Drug Enforcement Administration "prescription series" proposal: continuing concerns.
    Gilson AM; Joranson DE
    J Pain Palliat Care Pharmacother; 2007; 21(4):21-4. PubMed ID: 18032312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulating off-label drug use--rethinking the role of the FDA.
    Stafford RS
    N Engl J Med; 2008 Apr; 358(14):1427-9. PubMed ID: 18385495
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescription for passing inspection.
    Rossi MS
    N Y State Dent J; 2007; 73(4):6-7. PubMed ID: 17891874
    [No Abstract]   [Full Text] [Related]  

  • 20. Should the DEA conduct a "patient impact assessment" when promulgating new restrictions on controlled substance distribution?
    Brushwood DB
    J Pain Palliat Care Pharmacother; 2008; 22(4):322-6. PubMed ID: 21923319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.